Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types

Journal of Human Genetics volume 65, pages 79–89 (2020)Cite this article

Subjects

Abstract

Neurofibromatosis type 1 (NF1) is caused by heterozygous mutation in the NF1 gene. NF1 is one of the most common human genetic diseases. However, the overall genotype–phenotype correlation has not been known, due to a wide spectrum of genotypic and phenotypic heterogeneity. Here we describe the detailed clinical and genetic features of 427 Korean NF1 patients from 389 unrelated families. Long range PCR and sequencing of genomic DNA with multiplex ligation-dependent probe amplification analysis identified 250 different NF1 mutations in 363 families (93%), including 94 novel mutations. With an emphasis on phenotypes requiring medical attention (classified and termed: NF1+), we investigated the correlation of NF1+ and mutation types. NF1+ was more prevalent in patients with truncating/splicing mutations and large deletions than in those with missense mutations (59.6%, 64.3% vs. 36.6%, p = 0.001). This difference was especially significant in the patients younger than age 19 years. The number of items in NF1+ was a higher in the former groups (0.95 ± 0.06, 1.18 ± 0.20 vs. 0.56 ± 0.10, p = 0.002). These results suggest that mutation types are associated not only with higher prevalence of severe phenotypes in NF1 but also with their earlier onset.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89:1–6.

    CAS  PubMed  Google Scholar 

  2. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990;63:851–9.

    CAS  PubMed  Google Scholar 

  3. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990;63:843–9.

    CAS  PubMed  Google Scholar 

  4. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81–8.

    CAS  PubMed  Google Scholar 

  5. NIH. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Bethesda, Md., USA, July 13–15, 1987. Neurofibromatosis. 1988;1:172–8.

  6. DeBella K, Poskitt K, Szudek J, Friedman JM. Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology. 2000;54:1646–51.

    CAS  PubMed  Google Scholar 

  7. Pros E, Gomez C, Martin T, Fabregas P, Serra E, Lazaro C. Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. Hum Mutat. 2008;29:E173–93.

    PubMed  Google Scholar 

  8. Wimmer K, Roca X, Beiglbock H, Callens T, Etzler J, Rao AR, et al. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5’ splice-site disruption. Hum Mutat. 2007;28:599–612.

    CAS  PubMed  Google Scholar 

  9. van Minkelen R, van Bever Y, Kromosoeto JN, Withagen-Hermans CJ, Nieuwlaat A, Halley DJ, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85:318–27.

    PubMed  Google Scholar 

  10. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kucukceylan N, et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000;66:790–818.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanche H, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34:1510–8.

    CAS  PubMed  Google Scholar 

  12. Valero MC, Martin Y, Hernandez-Imaz E, Marina Hernandez A, Melean G, Valero AM, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol diagnostics. 2011;13:113–22.

    CAS  Google Scholar 

  13. Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes, Chromosom Cancer. 2006;45:265–76.

    CAS  Google Scholar 

  14. Moon JS, Lee SY, Nam CM, Choi J-M, Choe B-K, Seo J-W, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr. 2008;51:1–25.

    Google Scholar 

  15. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

    PubMed  PubMed Central  Google Scholar 

  16. Kehrer-Sawatzki H, Mautner VF, Cooper DN. Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet. 2017;136:349–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. De Luca A, Schirinzi A, Buccino A, Bottillo I, Sinibaldi L, Torrente I, et al. Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1. Hum Mutat. 2004;23:629.

    PubMed  Google Scholar 

  18. Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M. Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet. 2003;40:e109.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Mautner VF, Kluwe L, Friedrich RE, Roehl AC, Bammert S, Hogel J, et al. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet. 2010;47:623–30.

    CAS  PubMed  Google Scholar 

  20. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, et al. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 2010;31:E1506–18.

    CAS  PubMed  Google Scholar 

  21. Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007;80:140–51.

    CAS  PubMed  Google Scholar 

  22. Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S, et al. Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848. Am J Hum Genet. 2018;102:69–87.

    CAS  PubMed  Google Scholar 

  23. Pinna V, Lanari V, Daniele P, Consoli F, Agolini E, Margiotti K, et al. p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet. 2015;23:1068–71.

    CAS  PubMed  Google Scholar 

  24. Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum Mutat. 2015;36:1052–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Barrea C, Vaessen S, Bulk S, Harvengt J, Misson JP. Phenotype-genotype correlation in children with neurofibromatosis type 1. Neuropediatrics. 2018;49:180–84.

    CAS  PubMed  Google Scholar 

  26. Welti S, Kühn S, D’Angelo I, Brügger B, Kaufmann D, Scheffzek K. Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin. Hum Mutat. 2011;32:191–97.

    CAS  PubMed  Google Scholar 

  27. Rad E, Tee AR. Neurofibromatosis type 1: fundamental insights into cell signalling and cancer. Seminars Cell Dev Biol. 2016;52:39–46.

    CAS  Google Scholar 

  28. Rieley MB, Stevenson DA, Viskochil DH, Tinkle BT, Martin LJ, Schorry EK. Variable expression of neurofibromatosis 1 in monozygotic twins. Am J Med Genet Part A. 2011;155a:478–85.

    PubMed  Google Scholar 

  29. Cali F, Chiavetta V, Ruggeri G, Piccione M, Selicorni A, Palazzo D, et al. Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM platform. Eur J Med Genet. 2017;60:93–9.

    PubMed  Google Scholar 

  30. Pasmant E, Parfait B, Luscan A, Goussard P, Briand-Suleau A, Laurendeau I, et al. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet. 2015;23:596–601.

    CAS  PubMed  Google Scholar 

  31. Maruoka R, Takenouchi T, Torii C, Shimizu A, Misu K, Higasa K, et al. The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study. Genet Test Mol Biomark. 2014;18:722–35.

    CAS  Google Scholar 

  32. Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, et al. Clinical and Mutational Spectrum of Neurofibromatosis Type 1–like Syndrome. JAMA. 2009;302:2111–18.

    CAS  PubMed  Google Scholar 

  33. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988;111:1355–81.

    PubMed  Google Scholar 

  34. Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997;70:138–43.

    CAS  PubMed  Google Scholar 

  35. McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, et al. A clinical study of type 1 neurofibromatosis in north west England. J Med Genet. 1999;36:197–203.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, et al. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One. 2012;7:e35711.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med child Neurol. 2013;55:111–25.

    PubMed  Google Scholar 

  38. Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013;132:e1642–8.

    PubMed  Google Scholar 

  39. Garg S, Plasschaert E, Descheemaeker MJ, Huson S, Borghgraef M, Vogels A, et al. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord. 2015;45:1649–57.

    PubMed  Google Scholar 

  40. Schwetye KE, Gutmann DH. Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions. Expert Rev Neurother. 2014;14:1139–52.

    CAS  PubMed  Google Scholar 

  41. Torres Nupan MM, Velez Van Meerbeke A, Lopez Cabra CA, Herrera Gomez PM. Cognitive and behavioral disorders in children with neurofibromatosis type 1. Front Pediatrics. 2017;5:227.

    Google Scholar 

  42. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15:541–55.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We deeply appreciate the patients and their families for participating in this study.

Funding

This research was supported in part by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (NRF-2015K1A4A3046807 and NRF-2018M3A9H1078335).

Author information

Authors and Affiliations

  1. Department of Pediatrics, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea

    Eungu Kang

  2. Department of Pediatrics, Gangneung Asan Hospital, Gangneung, Republic of Korea

    Yoon-Myung Kim

  3. Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, 88, Olympic-ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea

    Go Hun Seo, Arum Oh, Heyry Kim, Han-Wook Yoo & Beom Hee Lee

  4. Department of Radiology and Research Institute of Radiology, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Hee Mang Yoon

  5. Departments of Neurosurgery, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Young-Shin Ra

  6. Department of Plastic Surgery, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Eun Key Kim

  7. Asan Institute for Life Sciences, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Sun-Hee Heo

  8. Medical Genetics Center, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Gu-Hwan Kim, Han-Wook Yoo & Beom Hee Lee

  9. Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota Medical School, Minneapolis, MN, USA

    Mark J. Osborn & Jakub Tolar

Authors
  1. Eungu Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoon-Myung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Go Hun Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arum Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hee Mang Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Young-Shin Ra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eun Key Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Heyry Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sun-Hee Heo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gu-Hwan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mark J. Osborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jakub Tolar
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Han-Wook Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Beom Hee Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beom Hee Lee.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, E., Kim, YM., Seo, G.H. et al. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types. J Hum Genet 65, 79–89 (2020). https://doi.org/10.1038/s10038-019-0695-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-019-0695-0

This article is cited by

Search

Advanced search

Quick links